All the SCIO's backers have been talking about Natrecor being a Blockbuster Drug, but no one in the press has been emphasizing the potential. We have finally gotten a few comments and write ups discussing everything we have been talking about for the past year on this board. Isaac and many others have been right on with the possibilities, but it doesn't matter until Wall Street gets it. IDPH and BGEN have market caps that can be barometers for SCIO's potential based upon revenues and pipeline. I believe Wall Street is starting to get it and funds are buying. $25 is a steal!
The market will wait until it sees a few quarters of sales and sees steady progress before the market cap moves up...this happened with Idec also...the market wants to avoid a disappointment like Ilex.